These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 26350228)

  • 1. Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results.
    Giżewska M; MacDonald A; Bélanger-Quintana A; Burlina A; Cleary M; Coşkun T; Feillet F; Muntau AC; Trefz FK; van Spronsen FJ; Blau N
    Eur J Pediatr; 2016 Feb; 175(2):261-72. PubMed ID: 26350228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of phenylketonuria in Europe: survey results from 19 countries.
    Blau N; Bélanger-Quintana A; Demirkol M; Feillet F; Giovannini M; MacDonald A; Trefz FK; van Spronsen F;
    Mol Genet Metab; 2010 Feb; 99(2):109-15. PubMed ID: 19800826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?
    Pinto A; Ahring K; Almeida MF; Ashmore C; Bélanger-Quintana A; Burlina A; Coşkun T; Daly A; van Dam E; Dursun A; Evans S; Feillet F; Giżewska M; Gökmen-Özel H; Hickson M; Hoekstra Y; Ilgaz F; Jackson R; Leśniak A; Loro C; Malicka K; Patalan M; Rocha JC; Sivri S; Rodenburg I; van Spronsen F; Strączek K; Tokatli A; MacDonald A
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary management practices in phenylketonuria across European centres.
    Ahring K; Bélanger-Quintana A; Dokoupil K; Gokmen Ozel H; Lammardo AM; MacDonald A; Motzfeldt K; Nowacka M; Robert M; van Rijn M
    Clin Nutr; 2009 Jun; 28(3):231-6. PubMed ID: 19362397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early feeding practices in infants with phenylketonuria across Europe.
    Pinto A; Adams S; Ahring K; Allen H; Almeida MF; Garcia-Arenas D; Arslan N; Assoun M; Atik Altınok Y; Barrio-Carreras D; Belanger Quintana A; Bernabei SM; Bontemps C; Boyle F; Bruni G; Bueno-Delgado M; Caine G; Carvalho R; Chrobot A; Chyż K; Cochrane B; Correia C; Corthouts K; Daly A; De Leo S; Desloovere A; De Meyer A; De Theux A; Didycz B; Dijsselhof ME; Dokoupil K; Drabik J; Dunlop C; Eberle-Pelloth W; Eftring K; Ekengren J; Errekalde I; Evans S; Foucart A; Fokkema L; François L; French M; Forssell E; Gingell C; Gonçalves C; Gökmen Özel H; Grimsley A; Gugelmo G; Gyüre E; Heller C; Hensler R; Jardim I; Joost C; Jörg-Streller M; Jouault C; Jung A; Kanthe M; Koç N; Kok IL; Kozanoğlu T; Kumru B; Lang F; Lang K; Liegeois I; Liguori A; Lilje R; Ļubina O; Manta-Vogli P; Mayr D; Meneses C; Newby C; Meyer U; Mexia S; Nicol C; Och U; Olivas SM; Pedrón-Giner C; Pereira R; Plutowska-Hoffmann K; Purves J; Re Dionigi A; Reinson K; Robert M; Robertson L; Rocha JC; Rohde C; Rosenbaum-Fabian S; Rossi A; Ruiz M; Saligova J; Gutiérrez-Sánchez A; Schlune A; Schulpis K; Serrano-Nieto J; Skarpalezou A; Skeath R; Slabbert A; Straczek K; Giżewska M; Terry A; Thom R; Tooke A; Tuokkola J; van Dam E; van den Hurk TAM; van der Ploeg EMC; Vande Kerckhove K; Van Driessche M; van Wegberg AMJ; van Wyk K; Vasconcelos C; Velez García V; Wildgoose J; Winkler T; Żółkowska J; Zuvadelli J; MacDonald A
    Mol Genet Metab Rep; 2018 Sep; 16():82-89. PubMed ID: 30101073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenges of managing coexistent disorders with phenylketonuria: 30 cases.
    MacDonald A; Ahring K; Almeida MF; Belanger-Quintana A; Blau N; Burlina A; Cleary M; Coskum T; Dokoupil K; Evans S; Feillet F; Giżewska M; Gokmen Ozel H; Lotz-Havla AS; Kamieńska E; Maillot F; Lammardo AM; Muntau AC; Puchwein-Schwepcke A; Robert M; Rocha JC; Santra S; Skeath R; Strączek K; Trefz FK; van Dam E; van Rijn M; van Spronsen F; Vijay S
    Mol Genet Metab; 2015 Dec; 116(4):242-51. PubMed ID: 26498184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
    Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
    Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylketonuria screening and management in southeastern Europe - survey results from 11 countries.
    Zerjav Tansek M; Groselj U; Angelkova N; Anton D; Baric I; Djordjevic M; Grimci L; Ivanova M; Kadam A; Kotori V; Maksic H; Marginean O; Margineanu O; Miljanovic O; Moldovanu F; Muresan M; Nanu M; Samardzic M; Sarnavka V; Savov A; Stojiljkovic M; Suzic B; Tincheva R; Tahirovic H; Toromanovic A; Usurelu N; Battelino T
    Orphanet J Rare Dis; 2015 May; 10():68. PubMed ID: 26025111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to clinic recommendations among patients with phenylketonuria in the United States.
    Jurecki ER; Cederbaum S; Kopesky J; Perry K; Rohr F; Sanchez-Valle A; Viau KS; Sheinin MY; Cohen-Pfeffer JL
    Mol Genet Metab; 2017 Mar; 120(3):190-197. PubMed ID: 28162992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Control of Patients with Phenylketonuria in a Portuguese Metabolic Centre Comparing Three Different Recommendations.
    Kanufre V; Almeida MF; Barbosa CS; Carmona C; Bandeira A; Martins E; Rocha S; Guimas A; Ribeiro R; MacDonald A; Pinto A; Rocha JC
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34578995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKU-what is daily practice in various centres in Europe? Data from a questionnaire by the scientific advisory committee of the European Society of Phenylketonuria and Allied Disorders.
    van Spronsen FJ; Ahring KK; Gizewska M
    J Inherit Metab Dis; 2009 Feb; 32(1):58-64. PubMed ID: 19191005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European Phenylketonuria Guidelines and the challenges on management practices in Portugal.
    Sousa C; Almeida MF; Sousa Barbosa C; Martins E; Janeiro P; Tavares de Almeida I; MacDonald A; Rocha JC
    J Pediatr Endocrinol Metab; 2019 Jun; 32(6):623-629. PubMed ID: 31141484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Practices and Challenges in the Diagnosis and Management of PKU in Latin America: A Multicenter Survey.
    Poloni S; Dos Santos BB; Chiesa A; Specola N; Pereyra M; Saborío-Rocafort M; Salazar MF; Leal-Witt MJ; Castro G; Peñaloza F; Wong SP; Porras RB; Paranza LO; Sanabria MC; Amieva MV; Morales M; Naranjo ARC; Mahfoud A; Colmenares AR; Lemes A; Sotillo-Lindo JF; Perez C; Rey LM; Torriente GMZ; Refosco LF; Schwartz IVD; Cornejo V
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of sapropterin before and during pregnancy: Final analysis of the Kuvan® Adult Maternal Paediatric European Registry (KAMPER) maternal and Phenylketonuria Developmental Outcomes and Safety (PKUDOS) PKU-MOMs sub-registries.
    Feillet F; Ficicioglu C; Lagler FB; Longo N; Muntau AC; Burlina A; Trefz FK; van Spronsen FJ; Arnoux JB; Lindstrom K; Lilienstein J; Clague GE; Rowell R; Burton BK;
    J Inherit Metab Dis; 2024 Jul; 47(4):636-650. PubMed ID: 38433424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional management of phenylalanine hydroxylase (PAH) deficiency in pediatric patients in Canada: a survey of dietitians' current practices.
    Yuskiv N; Potter BK; Stockler S; Ueda K; Giezen A; Cheng B; Langley E; Ratko S; Austin V; Chapman M; Chakraborty P; Collet JP; Pender A;
    Orphanet J Rare Dis; 2019 Jan; 14(1):7. PubMed ID: 30621767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for the use of sapropterin in phenylketonuria.
    Cunningham A; Bausell H; Brown M; Chapman M; DeFouw K; Ernst S; McClure J; McCune H; O'Steen D; Pender A; Skrabal J; Wessel A; Jurecki E; Shediac R; Prasad S; Gillis J; Cederbaum S
    Mol Genet Metab; 2012 Jul; 106(3):269-76. PubMed ID: 22575621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sapropterin dihydrochloride use in pregnant women with phenylketonuria: an interim report of the PKU MOMS sub-registry.
    Grange DK; Hillman RE; Burton BK; Yano S; Vockley J; Fong CT; Hunt J; Mahoney JJ; Cohen-Pfeffer JL; ;
    Mol Genet Metab; 2014 May; 112(1):9-16. PubMed ID: 24667082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria.
    Vernon HJ; Koerner CB; Johnson MR; Bergner A; Hamosh A
    Mol Genet Metab; 2010 Jul; 100(3):229-33. PubMed ID: 20418136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal phenylalanine wash-out in phenylketonuria.
    Porta F; Ponzone A; Spada M
    Metab Brain Dis; 2020 Oct; 35(7):1225-1229. PubMed ID: 32661828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine monitoring in children with early and continuously treated phenylketonuria: results of an international practice survey.
    Sharman R; Sullivan KA; Young RM; McGill JJ
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S417-20. PubMed ID: 20882350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.